BioAtla, Inc. BCAB

1.48 (0.04) (2.63%) as of 25 Sep
Market cap
$2.9M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
7.12 49.05 111.47 215.51 244.98 238.61 3.70 10.86 —
Other current assets
— — — — — — — 1.80 —
Total current assets
8.01 51.23 116.41 220.43 247.29 240.68 4.51 12.66 —
Property, Plant, Equpment (Net)
0.12 0.68 1.60 2.73 3.68 4.10 4.68 3.88 —
Long-term assets (Other)
0.16 — 0.15 0.15 0.15 0.15 0.15 0.10 —
Total non-current assets
5.82 1.19 3.25 5.31 7.13 4.26 4.83 — —
Total Assets
13.83 52.42 119.66 225.74 254.42 244.94 9.34 16.64 0.00
Accounts Payable
16.35 13.70 26.72 21.61 18.42 12.07 11.97 1.96 —
Accrued Expenses
— — — — — — 3.25 — —
Current Part of Debt
— — — 1.52 1.39 — 9.71 — —
Current Revenue (Deferred)
— — — — 0.00 20.19 1.79 — —
Other current liabilities
4.14 — — 17.38 17.25 29.81 11.87 7.24 —
Total current liabilities
21.92 14.54 28.34 23.13 19.81 32.26 26.72 9.20 —
Long Term Debt (Total)
— — — 2.46 3.98 0.68 8.41 15.00 —
Non-current Revenue (Deferred)
— — — — 0.00 2.02 21.00 0.31 —
Non-current Liabilities (Other)
23.32 23.62 19.81 19.81 19.81 0.01 9.22 20.58 —
Total non-current liabilities
28.10 23.62 20.64 22.27 23.79 2.70 38.63 — —
Total liabilities
50.02 38.16 48.99 45.40 43.60 34.96 65.35 45.08 —
Additional Paid In Capital
509.45 500.30 486.93 473.14 397.14 300.89 2.30 — —
Preferred Stock (Total)
— — — — — — 90.10 — —
Common Stock (Net)
0.01 0.01 0.01 0.01 0.00 0.00 0.75 0.75 —
Retained Earnings
(545.65) (486.04) (416.26) (292.80) (186.32) (90.92) (148.35) (118.56) —
Common Equity (Total)
(36.19) 14.27 70.67 180.34 210.82 209.97 (146.11) (117.81) —
Shareholders Equity (Total)
(36.19) 14.27 70.67 180.34 210.82 209.97 (56.01) (28.46) —
Shareholders Equity and Liabilities (Total)
13.83 52.42 119.66 225.74 254.42 244.94 9.34 — —
Shares (Common)
1.27 1.16 0.96 0.95 0.75 0.67 — — —
Shares (Preferred)
— — — — — 0.00 1.57 — —
Shareholders Equity (Tangible)
(36.19) 14.27 70.67 180.34 210.82 209.97 (56.01) — —
Net Debt
(7.12) (49.05) (111.47) (211.53) (239.61) (237.92) 14.42 4.14 —
Total Debt
— — — 3.98 5.37 0.68 18.12 15.00 —

Fold the line items

In millions of $ except per-share values · columns are period end dates